Company · Healthtech & Bio

OWL Metabolomics

www.rubiometabolomics.com ↗ ·Derio ·Other

OWL Metabolomics (legally One Way Liver, S.L., originally One Way Liver Genomics) is a Basque biotech spin-off of CIC bioGUNE founded in 2002-2004 in Derio (Bizkaia) that applies UHPLC-MS metabolomics to liver disease, commercialising the OWLiver and OWLiver Care non-invasive serum diagnostics for NAFLD/MASLD and NASH/MASH plus contract metabolomics R&D services for pharma and clinical trials. It was acquired by Laboratorios Rubió on 14 June 2023 and rebranded as Rubió Metabolomics, so it is no longer an independent company; its HQ is Parque Tecnológico de Bizkaia, Derio. Historic partnerships include Cerba Research/BARC Lab for deploying metabolomics in clinical trials.

Founded

2002

Founders

News

Rounds

Investors

SectorsBiotech, Metabolomics, Diagnostics, Liver disease / NASH-MASH, Life sciences R&D services Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Profile updated 9 Aug 2026

Founders

José María Mato

Co-founder (scientific founder); Scientific Advisory Board member

—

Global models

No comparables on record yet.

Investors 6

CRB Inverbio (Cross Road Biotech)

www.crbinverbio.com

Investor Spain

Fundació Clínic per a la Recerca Biomèdica

www.fundacioclinic.org ↗

Investor Spain

Gestión de Capital Riesgo del País Vasco

www.grupospri.eus ↗

Investor Spain

Institute for Research in Biomedicine (IRB Barcelona)

www.irbbarcelona.org ↗

Investor Spain

Kereon Partners

kereonpartners.com

Investor Spain

The Crowd Angel

www.thecrowdangel.com ↗

Investor Spain

Funding rounds

No announced rounds on record.

News & media 7

Published	Article
2024-08-08	Rubió Metabolomics contributes to the publication One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population ↗ Rubió Metabolomics (press release)
2024-07-08	Quality Management Reinforced with ISO Certifications ↗ Rubió Metabolomics (press release)
2023-12-20	Data Science Decoded: Mastering Workflow Management in the Big Data Era ↗ Rubió Metabolomics
2023-12-20	Rubió Metabolomics and VCU's Stravitz-Sanyal Institute Sign Collaboration Agreement for Liver Disease Research ↗ Rubió Metabolomics (press release)
2023-11-08	Rubió Metabolomics and Health in Code Sign Agreement to Expand Service Offering ↗ Rubió Metabolomics (press release)
2023-10-11	Rubió Metabolomics Announces Scientific and Commercial Participation at The Liver Meeting® 2023 ↗ Rubió Metabolomics (press release)
2023-08-30	OWL Metabolomics contributes to MASEF Score for Identifying At-Risk MASH Patients ↗ Basque Health Cluster